This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
Best used under guidance from a qualified professional
However, there are also capsule-based formulas available that include Ac-SDKP, a TB-500 fragment with enhanced oral bioavailability compared to the full peptide sequence of thymosin beta-4
Learn More Get in touch with an expert near you
Medical directors need to review protocols, especially if a patient doesn't respond after 4-6 weeks, side effects appear, or new regulations come up
Mechanisms of Action: The Core Difference This is where the two compounds genuinely diverge